# Alexandria Real Estate Equities, Inc.: financial statements, quarterly

ARE · NYSE · CIK 1035443 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/are.md) · [Financials](/companies/are/financials.md) · [Filings](/companies/are/filings.md) · [Insiders](/companies/are/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/are/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [757 d](/filings/0001035443-26-000013.md) | [769](/filings/0001035443-25-000136.md) | [767](/filings/0001035443-25-000179.md) | [792](/filings/0001035443-25-000198.md) | [789 d](/filings/0001035443-26-000013.md) | [758](/filings/0001035443-26-000042.md) | [762](/filings/0001035443-26-000066.md) | [752](/filings/0001035443-26-000076.md) | [754 d](/filings/0001035443-26-000013.md) | [671](/filings/0001035443-26-000042.md) | [663](/filings/0001035443-26-000066.md) | [671](/filings/0001035443-26-000076.md) |
| Interest expense | $m | [32.0 d](/filings/0001035443-26-000013.md) | [40.8](/filings/0001035443-25-000136.md) | [45.8](/filings/0001035443-25-000179.md) | [43.6](/filings/0001035443-25-000198.md) | [55.7 d](/filings/0001035443-26-000013.md) | [50.9](/filings/0001035443-26-000042.md) | [55.3](/filings/0001035443-26-000066.md) | [54.9](/filings/0001035443-26-000076.md) | [65.7 d](/filings/0001035443-26-000013.md) | [64.6](/filings/0001035443-26-000042.md) | [64.3](/filings/0001035443-26-000066.md) | [79.7](/filings/0001035443-26-000076.md) |
| Net income | $m | [(88.4) d](/filings/0001035443-26-000013.md) | [171](/filings/0001035443-25-000136.md) | [46.7](/filings/0001035443-25-000179.md) | [168](/filings/0001035443-25-000198.md) | [(62.2) d](/filings/0001035443-26-000013.md) | [(8.9)](/filings/0001035443-26-000042.md) | [(107)](/filings/0001035443-26-000066.md) | [(233)](/filings/0001035443-26-000076.md) | [(1,081) d](/filings/0001035443-26-000013.md) | [362](/filings/0001035443-26-000042.md) | [(72.8)](/filings/0001035443-26-000066.md) | [(638)](/filings/0001035443-26-000076.md) |
| Diluted EPS | $ per share | not reported | [0.97](/filings/0001035443-25-000136.md) | [0.25](/filings/0001035443-25-000179.md) | [0.96](/filings/0001035443-25-000198.md) | not reported | [(0.07)](/filings/0001035443-26-000042.md) | [(0.64)](/filings/0001035443-26-000066.md) | [(1.38)](/filings/0001035443-26-000076.md) | not reported | [2.10](/filings/0001035443-26-000042.md) | [(0.43)](/filings/0001035443-26-000066.md) | [(3.74)](/filings/0001035443-26-000076.md) |
| Basic EPS | $ per share | not reported | [0.97](/filings/0001035443-25-000136.md) | [0.25](/filings/0001035443-25-000179.md) | [0.96](/filings/0001035443-25-000198.md) | not reported | [(0.07)](/filings/0001035443-26-000042.md) | [(0.64)](/filings/0001035443-26-000066.md) | [(1.38)](/filings/0001035443-26-000076.md) | not reported | [2.10](/filings/0001035443-26-000042.md) | [(0.43)](/filings/0001035443-26-000066.md) | [(3.74)](/filings/0001035443-26-000076.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001035443-25-000067.md) | [0.7](/filings/0001035443-24-000158.md) | [0.6](/filings/0001035443-24-000225.md) | [0.6](/filings/0001035443-24-000298.md) | [0.6](/filings/0001035443-26-000013.md) | [0.5](/filings/0001035443-25-000136.md) | [0.5](/filings/0001035443-25-000179.md) | [0.6](/filings/0001035443-25-000198.md) | [0.5](/filings/0001035443-26-000076.md) | [0.4](/filings/0001035443-26-000042.md) | [0.5](/filings/0001035443-26-000066.md) | [0.5](/filings/0001035443-26-000076.md) |
| Total assets | $bn | [36.8](/filings/0001035443-25-000067.md) | [37.7](/filings/0001035443-24-000158.md) | [37.8](/filings/0001035443-24-000225.md) | [38.5](/filings/0001035443-24-000298.md) | [37.5](/filings/0001035443-26-000013.md) | [37.6](/filings/0001035443-25-000136.md) | [37.6](/filings/0001035443-25-000179.md) | [37.4](/filings/0001035443-25-000198.md) | [34.1](/filings/0001035443-26-000076.md) | [34.2](/filings/0001035443-26-000042.md) | [34.6](/filings/0001035443-26-000066.md) | [34.1](/filings/0001035443-26-000076.md) |
| Total liabilities | $bn | [14.1](/filings/0001035443-25-000067.md) | [14.9](/filings/0001035443-24-000158.md) | [15.2](/filings/0001035443-24-000225.md) | [15.8](/filings/0001035443-24-000298.md) | [15.1](/filings/0001035443-26-000013.md) | [15.6](/filings/0001035443-25-000136.md) | [15.9](/filings/0001035443-25-000179.md) | [16.3](/filings/0001035443-25-000198.md) | [14.9](/filings/0001035443-26-000076.md) | [14.8](/filings/0001035443-26-000042.md) | [15.5](/filings/0001035443-26-000066.md) | [15.6](/filings/0001035443-26-000076.md) |
| Long-term debt | $bn | [11.3](/filings/0001035443-24-000072.md) | [12.2](/filings/0001035443-24-000158.md) | [12.4](/filings/0001035443-24-000225.md) | [12.7](/filings/0001035443-24-000298.md) | [12.2](/filings/0001035443-25-000067.md) | [13.1](/filings/0001035443-25-000136.md) | [13.3](/filings/0001035443-25-000179.md) | [13.6](/filings/0001035443-25-000198.md) | [12.4](/filings/0001035443-26-000013.md) | [12.5](/filings/0001035443-26-000042.md) | [12.8](/filings/0001035443-26-000066.md) | [12.9](/filings/0001035443-26-000076.md) |
| Shareholders' equity | $bn | [18.5](/filings/0001035443-25-000067.md) | [18.4](/filings/0001035443-24-000158.md) | [18.3](/filings/0001035443-24-000225.md) | [18.2](/filings/0001035443-24-000298.md) | [17.9](/filings/0001035443-26-000013.md) | [17.5](/filings/0001035443-25-000136.md) | [17.2](/filings/0001035443-25-000179.md) | [16.6](/filings/0001035443-25-000198.md) | [15.5](/filings/0001035443-26-000076.md) | [15.7](/filings/0001035443-26-000042.md) | [15.6](/filings/0001035443-26-000066.md) | [14.8](/filings/0001035443-26-000076.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [429 d](/filings/0001035443-26-000013.md) | [341](/filings/0001035443-25-000136.md) | [412 d](/filings/0001035443-25-000179.md) | [477 d](/filings/0001035443-25-000198.md) | [274 d](/filings/0001035443-26-000013.md) | [208](/filings/0001035443-26-000042.md) | [460 d](/filings/0001035443-26-000066.md) | [433 d](/filings/0001035443-26-000076.md) | [312 d](/filings/0001035443-26-000013.md) | [197](/filings/0001035443-26-000042.md) | [337 d](/filings/0001035443-26-000066.md) | [342 d](/filings/0001035443-26-000076.md) |
| Dividends paid | $m | [214 d](/filings/0001035443-26-000013.md) | [222](/filings/0001035443-25-000136.md) | [222 d](/filings/0001035443-25-000179.md) | [227 d](/filings/0001035443-25-000198.md) | [227 d](/filings/0001035443-26-000013.md) | [230](/filings/0001035443-26-000042.md) | [227 d](/filings/0001035443-26-000066.md) | [227 d](/filings/0001035443-26-000076.md) | [227 d](/filings/0001035443-26-000013.md) | [124](/filings/0001035443-26-000042.md) | [124 d](/filings/0001035443-26-000066.md) | [124 d](/filings/0001035443-26-000076.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0001035443-25-000136.md) | [0.0 d](/filings/0001035443-25-000179.md) | [0.0 d](/filings/0001035443-25-000198.md) | [50.1 d](/filings/0001035443-26-000013.md) | [208](/filings/0001035443-26-000042.md) | [0.0 d](/filings/0001035443-26-000066.md) | [0.0 d](/filings/0001035443-26-000076.md) | [0.0 d](/filings/0001035443-26-000013.md) | [0.0](/filings/0001035443-26-000042.md) | [0.0 d](/filings/0001035443-26-000066.md) | [0.0 d](/filings/0001035443-26-000076.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [171](/filings/0001035443-24-000158.md) | [171](/filings/0001035443-24-000225.md) | [171](/filings/0001035443-24-000298.md) | [172](/filings/0001035443-25-000136.md) | [172](/filings/0001035443-25-000179.md) | [172](/filings/0001035443-25-000198.md) | [171](/filings/0001035443-26-000042.md) | [170](/filings/0001035443-26-000066.md) | [170](/filings/0001035443-26-000076.md) | [171](/filings/0001035443-26-000042.md) | [171](/filings/0001035443-26-000066.md) | [171](/filings/0001035443-26-000076.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 174,160,645 at 2026-10-15, from the cover of the [10-Q filed 2026-10-26](/filings/0001035443-26-000076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:23 ET. No prices; not investment advice.